These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 19176629)
1. Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy. Karwacz K; Mukherjee S; Apolonia L; Blundell MP; Bouma G; Escors D; Collins MK; Thrasher AJ J Virol; 2009 Apr; 83(7):3094-103. PubMed ID: 19176629 [TBL] [Abstract][Full Text] [Related]
2. An Engineered DC-Targeting Lentivector Induces Robust T Cell Responses and Inhibits HBV Replication in HBV Transgenic Mice via Upregulating T Cell Autophagy. Ma S; Chen X; Tan Q; Dai S; Li D; Wu S; Yu Y; Zang G; Tang Z Cell Physiol Biochem; 2018; 48(3):1041-1059. PubMed ID: 30041239 [TBL] [Abstract][Full Text] [Related]
3. Lentivector immunization induces tumor antigen-specific B and T cell responses in vivo. Garcia Casado J; Janda J; Wei J; Chapatte L; Colombetti S; Alves P; Ritter G; Ayyoub M; Valmori D; Chen W; Lévy F Eur J Immunol; 2008 Jul; 38(7):1867-76. PubMed ID: 18546142 [TBL] [Abstract][Full Text] [Related]
4. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice. Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581 [TBL] [Abstract][Full Text] [Related]
5. Dendritic cell-directed lentivector vaccine induces antigen-specific immune responses against murine melanoma. Yang HG; Hu BL; Xiao L; Wang P Cancer Gene Ther; 2011 May; 18(5):370-80. PubMed ID: 21372855 [TBL] [Abstract][Full Text] [Related]
6. Engineered lentivector targeting of dendritic cells for in vivo immunization. Yang L; Yang H; Rideout K; Cho T; Joo KI; Ziegler L; Elliot A; Walls A; Yu D; Baltimore D; Wang P Nat Biotechnol; 2008 Mar; 26(3):326-34. PubMed ID: 18297056 [TBL] [Abstract][Full Text] [Related]
7. Lentiviral backbone-based hepatitis B virus replicon-mediated transfer favours the establishment of persistent hepatitis B virus infection in mice after hydrodynamic injection. Chuai X; Wang W; Chen H; Deng Y; Wen B; Tan W Antiviral Res; 2014 Jan; 101():68-74. PubMed ID: 24239872 [TBL] [Abstract][Full Text] [Related]
8. Targeting human telomerase reverse transcriptase with recombinant lentivector is highly effective to stimulate antitumor CD8 T-cell immunity in vivo. Adotévi O; Mollier K; Neuveut C; Dosset M; Ravel P; Fridman WH; Tartour E; Charneau P; Wain-Hobson S; Langlade-Demoyen P Blood; 2010 Apr; 115(15):3025-32. PubMed ID: 20130242 [TBL] [Abstract][Full Text] [Related]
10. Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity. He Y; Zhang J; Mi Z; Robbins P; Falo LD J Immunol; 2005 Mar; 174(6):3808-17. PubMed ID: 15749922 [TBL] [Abstract][Full Text] [Related]
11. Efficient transduction of dendritic cells and induction of a T-cell response by third-generation lentivectors. Esslinger C; Romero P; MacDonald HR Hum Gene Ther; 2002 Jun; 13(9):1091-100. PubMed ID: 12067442 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a self-inactivating lentiviral vector expressing simian immunodeficiency virus gag for induction of specific immune responses in vitro and in vivo. Buffa V; Negri DR; Leone P; Borghi M; Bona R; Michelini Z; Compagnoni D; Sgadari C; Ensoli B; Cara A Viral Immunol; 2006; 19(4):690-701. PubMed ID: 17201664 [TBL] [Abstract][Full Text] [Related]
13. Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth. Bryson PD; Han X; Truong N; Wang P Vaccine; 2017 Oct; 35(43):5842-5849. PubMed ID: 28916248 [TBL] [Abstract][Full Text] [Related]
14. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene. Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163 [TBL] [Abstract][Full Text] [Related]
15. Diminished Memory T-Cell Expansion Due to Delayed Kinetics of Antigen Expression by Lentivectors. Furmanov K; Elnekave M; Sa'eed A; Segev H; Eli-Berchoer L; Kotton DN; Bachrach G; Hovav AH PLoS One; 2013; 8(6):e66488. PubMed ID: 23824049 [TBL] [Abstract][Full Text] [Related]
16. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection. Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574 [TBL] [Abstract][Full Text] [Related]
17. Nonintegrating lentiviral vectors can effectively deliver ovalbumin antigen for induction of antitumor immunity. Hu B; Yang H; Dai B; Tai A; Wang P Hum Gene Ther; 2009 Dec; 20(12):1652-64. PubMed ID: 19663564 [TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-based vaccination with lentiviral vectors encoding ubiquitinated hepatitis B core antigen enhances hepatitis B virus-specific immune responses in vivo. Dai S; Zhuo M; Song L; Chen X; Yu Y; Tang Z; Zang G Acta Biochim Biophys Sin (Shanghai); 2015 Nov; 47(11):870-9. PubMed ID: 26373843 [TBL] [Abstract][Full Text] [Related]
19. Efficient induction of tumor antigen-specific CD8+ memory T cells by recombinant lentivectors. Chapatte L; Colombetti S; Cerottini JC; Lévy F Cancer Res; 2006 Jan; 66(2):1155-60. PubMed ID: 16424053 [TBL] [Abstract][Full Text] [Related]
20. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. Chow YH; Huang WL; Chi WK; Chu YD; Tao MH J Virol; 1997 Jan; 71(1):169-78. PubMed ID: 8985336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]